SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-026140
Filing Date
2022-07-15
Accepted
2022-07-15 18:00:32
Documents
2
Period of Report
2022-07-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4289
2 EX-24 DOCUMENT attachment1.htm EX-24 4749
  Complete submission text file 0000899243-22-026140.txt   10654
Mailing Address C/O SEER, INC. 3800 BRIDGE PARKWAY, SUITE 102 REDWOOD CITY CA 94065
Business Address
Farokhzad Omid (Reporting) CIK: 0001586852 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40440 | Film No.: 221087776

Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Issuer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)